drugset / Trial / NCT02667353

Neurorestorative Effects of Electroconvulsive Therapy (ECT) in Patients With Severe Late Life Depression

NCT02667353

NaSingle-groupOpen-labelBasic science

Summary

To study the potential neurorestorative effects of electroconvulsive therapy (ECT) in depressed patients by measuring brain derived neurotrophic factor (BDNF) serum levels and hippocampal volumes in severely depressed patients receiving ECT.

Timeline

Start
2011-06
Primary completion
2014-06
Completion
2015-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Etomidate Small molecule 0.2 mg/kg Intravenous
Background Suxamethonium Other / unclassified 1 mg/kg Intravenous

Indications